CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
2.305
+0.015 (0.66%)
Oct 9, 2025, 10:59 AM EDT - Market open
CollPlant Biotechnologies Stock Forecast
Stock Price Forecast
The 2 analysts that cover CollPlant Biotechnologies stock have a consensus rating of "Strong Buy" and an average price target of $11.5, which forecasts a 398.92% increase in the stock price over the next year. The lowest target is $11 and the highest is $12.
Price Target: $11.5 (+398.92%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CollPlant Biotechnologies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +420.61% | Sep 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +377.22% | Aug 21, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +420.61% | Aug 20, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +420.61% | May 30, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +420.61% | May 28, 2025 |
Financial Forecast
Revenue This Year
8.84M
from 515.00K
Increased by 1,617.28%
Revenue Next Year
16.23M
from 8.84M
Increased by 83.54%
EPS This Year
-0.32
from -1.45
EPS Next Year
-0.05
from -0.32
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 13.4M | 18.9M | |
| Avg | 8.8M | 16.2M | |
| Low | 4.5M | 13.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2,497.7% | 113.7% | |
| Avg | 1,617.3% | 83.5% | |
| Low | 775.3% | 53.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.11 | 0.01 | |
| Avg | -0.32 | -0.05 | |
| Low | -0.52 | -0.10 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.